Synthesis of branched antisense oligonucleotides having multiple specificities-Reference-Cited by-同舟云学术

Synthesis of branched antisense oligonucleotides having multiple specificities

Published:2006-01 Issue:6 Volume:67 Page:1375-1380
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Rubenstein Marvin,Anderson Kenning M.,Tsui Paulus,Guinan Patrick

Publisher

Elsevier BV

Subject

General Medicine

Reference17 articles.

1. Formulation of a three-stranded polynucleotide molecule;Felsenfeld;J Amer Chem Soc,1957

2. Phosphorothioate oligonucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix;Guvakova;J Biol Chem,1995

3. Inhibitory effect of antisense oligonucleotides targeting epidermal growth factor receptor may not be related to changes in mRNA levels in human prostate cancer cells;Rubenstein;Proc Am Assoc Cancer Res,2002

4. Inhibition of Rous sarcoma virus replication and transformation by a specific deoxynucleotide;Zamecnik;Proc Natl Acad Sci USA,1979

5. A review of antisense oligonucleotides in the treatment of human disease;Rubenstein;Drugs Future,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNase H-sensitive multifunctional ASO-based constructs as promising tools for the treatment of multifactorial complex pathologies;Bioorganic Chemistry;2024-09

2. In LNCaP Cells Inhibition of BCL-2 by Antisense Oligonucleonucleotides Results in Compensatory Changes in Apoptosis;Scientific Journal of Genetics and Gene Therapy;2014-03-27

3. Oligonucleotide suppression of bcl-2 in LNCaP cells is compensated by increased androgen sensitivity, p53 and oncogene activity, and suppressed caspase-3;Medical Oncology;2013-05-16

4. Increased expression of the androgen receptor with p300 and interleukin-6 coactivators compensate for oligonucleotide suppression of bcl-2: no increased CREB binding protein or interleukin-4 expression;Therapeutic Advances in Urology;2012-11-08

5. In LNCaP cells enhanced expression of both androgen receptor and costimulatory protein p300 compensate for antisense oligonucleotide suppression of bcl-2;Therapeutic Advances in Urology;2011-10-27